MNK Kinases Facilitate C-Myc IRES Activity in Rapamycin-Treated Multiple Myeloma Cells

Oncogene - United Kingdom
doi 10.1038/onc.2012.43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

IL-6-induced Enhancement of C-Myc Translation in Multiple Myeloma Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Myc Target in Myeloid Cells-1, a Novel C-Myc Target, Recapitulates Multiple C-Myc Phenotypes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

MNK Kinases Regulate Multiple TLR Pathways and Innate Proinflammatory Cytokines in Macrophages

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2008English

C-Myc Deregulation Is Involved in Melphalan Resistance of Multiple Myeloma: Role of PDGF-BB

International Journal of Immunopathology and Pharmacology
2006English

Treatment of Multiple Myeloma With VLA4-targeted Nanoparticles Delivering Novel C-Myc Inhibitor Prodrug

2012English

Wogonin Inhibits Multiple Myeloma-Stimulated Angiogenesis via C-Myc/VHL/HIF-1α Signaling Axis

Oncotarget
Oncology
2015English

Exploiting MYC-induced PARPness to Target Genomic Instability in Multiple Myeloma

Haematologica
Hematology
2020English

Translational Control of C-Myc by Rapamycin Promotes Terminal Myeloid Differentiation

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy